Beyond Physical Exercise: The Role of Nutrition, Gut Microbiota and Nutraceutical Supplementation in Reducing Age-Related Sarcopenia.


Journal

Current aging science
ISSN: 1874-6128
Titre abrégé: Curr Aging Sci
Pays: United Arab Emirates
ID NLM: 101473576

Informations de publication

Date de publication:
2021
Historique:
received: 03 07 2020
revised: 29 10 2020
accepted: 06 12 2020
pubmed: 5 2 2021
medline: 15 12 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

Sarcopenia is a commonly prevalent geriatric condition mainly characterized by progressive loss of the skeletal muscle mass that results in noticeably reduced muscle strength and quality. Most of the geriatric population above 60 years of age are overweight, leading to the accumulation of fat in the muscles resulting in abated muscle function. The increased loss of muscle mass is associated with high rates of disability, poor motility, frailty and mortality. The excessive degeneration of muscles is now also being observed in middle-aged people. Therefore, geriatrics has recently started shifting towards the identification of early stages of the disability in order to expand the life span of the patient and reduce physical dependence. Recent findings have indicated that patients with increased physical activity are also affected by sarcopenia, therefore indicating the role of nutritional supplements to enhance muscle health which in turn helps to counteract sarcopenia. Various interventions with physical training have not provided substantial improvements to this disorder, thereby highlighting the crucial role of nutritional supplementation in enhancing muscle mass and strength. Nutritional supplementation has not only been shown to enhance the positive effects of physical interventions but also have a profound impact on the gut microbiome that has come forward as a key regulator of muscle mass and function. This brief review throws light upon the efficiency of nutrients and nutraceutical supplementation by highlighting their ancillary effects in physical interventions as well as improving the gut microbiome status in sarcopenic adults, thereby giving rise to a multimodal intervention for the treatment of sarcopenia.

Identifiants

pubmed: 33535963
pii: CAS-EPUB-113879
doi: 10.2174/1874609814666210203090458
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-104

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Antara Banerjee (A)

Department of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Francesco Marotta (F)

ReGenera R&D International for Aging Intervention, Milan, Italy.

Sushmitha Sriramulu (S)

Department of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Yashna Chabria (Y)

Department of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Sruthi Hari (S)

Department of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Roberto Catanzaro (R)

Department of Clinical and Experimental Medicine, Section of Gastroenterology, University of Catania, Catania, Italy.

Mario Barbagallo (M)

Department of Geriatrics and Internal Medicine, University of Palermo, Rochester, Italy.

Baskar Balakrishnan (B)

Department of Immunology, Mayo Clinic, Rochester, MN, United States.

Fang He (F)

West China School of Public Health, Sichuan University, Sichuan, China.

Rajesh Kanna Nandagopal Radha (RK)

Department of Pathology, Faculty of Medicine, Chettinad Academy of Research and Education, Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Surajit Pathak (S)

Department of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603 103, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH